COVID-19

Overview

At the end of December 2019, Chinese public health authorities reported several cases of acute respiratory syndrome in Wuhan City, Hubei province, China. Chinese scientists soon identified a novel coronavirus as the main causative agent. The disease is now referred to as coronavirus disease 2019 (COVID-19), and the causative virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is a new strain of coronavirus that has not been previously identified in humans.

The initial outbreak in Wuhan spread rapidly, affecting other parts of China. Cases were soon detected in several other countries. Outbreaks and clusters of the disease have since been observed in Asia, Europe, Australia, Africa and the Americas.

For a quick overview, please refer to the following pages:

 

The COVID-19 pandemic is rapidly evolving, and outbreak investigations are ongoing. ECDC is closely monitoring this outbreak, providing risk assessments, public health guidance, and advice on response activities to EU Member States and the EU Commission.

Latest updates

Publication

Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – eighth update

Risk assessment -

Publication

Using face masks in the community - Reducing COVID-19 transmission from potentially asymptomatic or pre-symptomatic people through the use of face masks

Technical report -

Data

Download today’s data on the geographic distribution of COVID-19 cases worldwide

Table -

Publication

Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 – first update

Technical report -

Publication

Communicable disease threats report, 29 March-4 April 2020, week 14

Publication -

Situation update 8 April 2020, dataset collected 6:00-10:00 CET

1 391 890 cases
Worldwide
81 478 deaths
Whereof 55 826 deaths in the EU/EEA and the UK.
634 735 cases
in the EU/EEA and the UK.